Senator Risa Hontiveros, which critics dubbed as the ‘PhilHealth Queen,’ had been linked to fund controversies of the Philippine Health Insurance Corporation (PhilHealth) more than a decade ago.
Although multiple government audits and independent investigations have clarified the timeline of these events, the allegations are frequently recirculated in digital spaces to question her integrity.
The controversy centers on a 2013 Commission on Audit (COA) report that flagged ₱1.76 billion in unauthorized bonuses and allowances distributed to PhilHealth officials. Critics have frequently claimed that Hontiveros was responsible for or benefited from these disbursements during her time as a board member.
However, official government records clarify that these specific funds were approved and released throughout the year 2013 and early 2014. Hontiveros was only appointed to the PhilHealth Board of Directors as a consumer representative in November 2014.
Since the financial decisions and payouts occurred before her entry into the agency, she could not have authorized or received them.
Systematic Debunking by Credible Institutions
Independent fact-checkers and state agencies have addressed these claims at least ten separate times over the last decade to correct the public record.
In 2018, VERA Files confirmed that Hontiveros’ name does not appear on any COA Notice of Disallowance related to the 2013 bonus mess. Furthermore, the Office of the Ombudsman has never filed charges against her for these specific funds, and no court has issued a judgment finding her guilty.
News outlets like AFP Fact Check, Rappler and PressOne.PH consistently categorize these viral posts as “recycled fake news.” The continued use of these debunked claims is documented as a persistent tactic in political disinformation campaigns.
The 15 Billion Issue
Recent social media narratives have also attempted to link the Senator to the ₱15 billion “ghost” fund scandal that surfaced in August 2020. This link is chronologically impossible because Hontiveros resigned from PhilHealth in October 2015 to pursue her senatorial bid.
The 2020 scandal involved an Internal Reimbursement Mechanism (IRM) implemented by a completely different set of administrators years after her departure. During the height of that controversy, Hontiveros was actually one of the lead legislators who called for a Senate inquiry to track down the missing funds.
Her name has been linked to the 2020 anomaly in documented cases, combining two unrelated timelines.
The narrative suggesting Senator Risa Hontiveros was involved in PhilHealth corruption is refuted by the simple alignment of dates and official audit records. Every major investigation by the Commission on Audit and the Ombudsman confirms she was either not yet in office or had already left when these anomalies occurred.
